SAG Intrauterine contraceptive device inside endometrial cavity 2D ultrasound

A comprehensive investigation confirmed Ovaprene's non-hormonal design achieves consistent contraceptive efficacy, paving the way for further pivotal trials in pregnancy risk assessment.

In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.

After decades of disappointments, a new generation of male contraceptives is under development and expected to enable men to share the contraceptive burden with their female partners.

In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.